DOCSLIB.ORG

INTRODUCTION to LIPIDOMICS from Bacteria to Man

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
INTRODUCTION to LIPIDOMICS from Bacteria to Man INTRODUCTION TO LIPIDOMICS From Bacteria to Man INTRODUCTION TO LIPIDOMICS From Bacteria to Man CLAUDE LERAY Boca Raton London New York CRC Press is an imprint of the Taylor & Francis Group, an informa business CRC Press Taylor & Francis Group 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 © 2013 by Taylor & Francis Group, LLC CRC Press is an imprint of Taylor & Francis Group, an Informa business No claim to original U.S. Government works Version Date: 20120725 International Standard Book Number-13: 978-1-4665-5147-3 (eBook - PDF) This book contains information obtained from authentic and highly regarded sources. Reasonable efforts have been made to publish reliable data and information, but the author and publisher cannot assume responsibility for the validity of all materials or the consequences of their use. The authors and publishers have attempted to trace the copyright holders of all material reproduced in this publication and apologize to copyright holders if permission to publish in this form has not been obtained. If any copyright material has not been acknowledged please write and let us know so we may rectify in any future reprint. Except as permitted under U.S. Copyright Law, no part of this book may be reprinted, reproduced, transmitted, or utilized in any form by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying, micro- filming, and recording, or in any information storage or retrieval system, without written permission from the publishers. For permission to photocopy or use material electronically from this work, please access www.copyright.com (http://www. copyright.com/) or contact the Copyright Clearance Center, Inc. (CCC), 222 Rosewood Drive, Danvers, MA 01923, 978-750- 8400. CCC is a not-for-profit organization that provides licenses and registration for a variety of users. For organizations that have been granted a photocopy license by the CCC, a separate system of payment has been arranged. Trademark Notice: Product or corporate names may be trademarks or registered trademarks, and are used only for identi- fication and explanation without intent to infringe. Visit the Taylor & Francis Web site at http://www.taylorandfrancis.com and the CRC Press Web site at http://www.crcpress.com Contents Foreword ...................................................................................................................xi Preface.................................................................................................................... xiii Acknowledgments ..................................................................................................xvii About the Author ....................................................................................................xix Introduction .............................................................................................................xxi SECTION I Simple Lipids Chapter 1 Simple Lipids with Only One Component ...........................................3 1.1 Hydrocarbons ............................................................................3 1.1.1 Linear Hydrocarbons ....................................................3 1.1.2 Cyclic Hydrocarbons ....................................................5 1.1.3 Polycyclic Hydrocarbons ..............................................8 1.1.4 Hydrocarbons with a Heterocyclic Core .................... 11 1.2 Fatty Acids ...............................................................................15 1.2.1 Linear-Chain Fatty Acids ........................................... 16 1.2.1.1 General Properties ...................................... 16 1.2.1.2 Saturated Fatty Acids.................................. 17 1.2.1.3 Unsaturated Fatty Acids ............................. 19 1.2.2 Branched-Chain Fatty Acids ......................................29 1.2.2.1 Fatty Acids with One Methyl Group ..........30 1.2.2.2 Fatty Acids with Several Methyl Groups (Isoprenoid Type) ........................... 31 1.2.2.3 Mycolic Acids .............................................32 1.2.3 Fatty Acids with a Substituted Chain ......................... 33 1.2.3.1 Dicarboxylic Fatty Acids ............................ 33 1.2.3.2 Hydroxylated Fatty Acids ........................... 35 1.2.3.3 Fatty Acid Amides ......................................40 1.2.3.4 Methoxylated or Acetoxylated Fatty Acids ..................................................40 1.2.3.5 Ketonic Fatty Acids .................................... 41 1.2.3.6 Aldehydic Fatty Acids ................................42 1.2.3.7 Divinyl Ether Fatty Acids ...........................42 1.2.3.8 Carbonated Fatty Acids (or Dialkylcarbonates) ...................................... 43 1.2.3.9 Nitrated Fatty Acids .................................... 43 1.2.3.10 Halogenated Fatty Acids ............................. 43 1.2.3.11 Sulfated Fatty Acids and Thia Acids ..........45 v vi Contents 1.2.4 Ring-Containing Fatty Acids .....................................46 1.2.4.1 Cyclopropanic and Cyclopropenic Fatty Acids ..................................................46 1.2.4.2 Cyclobutylic Fatty Acids (Ladderanes) ...............................................46 1.2.4.3 Cyclopentylic and Cyclopentenylic Fatty Acids ..................................................46 1.2.4.4 Cyclohexylic and Cycloheptylic Fatty Acids ........................................................... 47 1.2.4.5 Furanoid Fatty Acids ..................................48 1.2.4.6 Epoxy Fatty Acids ......................................48 1.2.4.7 Cyclic Peroxy Fatty Acids ..........................50 1.2.4.8 Sulfur-Containing Fatty Acids ...................50 1.2.5 Phenylated Fatty Acids ............................................... 51 1.3 Hydroxylated or Cyclic Fatty Acid Derivatives ....................... 52 1.3.1 Lipoxygenase Products ............................................... 53 1.3.1.1 Hydroxylated Octadecanoid Acids ............. 53 1.3.1.2 Hydroxylated Eicosanoid Acids .................. 53 1.3.1.3 Hydroxylated Docosanoid Acids ................ 55 1.3.1.4 Leukotrienes and Analogues ......................57 1.3.1.5 Jasmonates ..................................................58 1.3.2 Prostanoids .................................................................59 1.3.2.1 Prostaglandins ............................................60 1.3.2.2 Prostacyclins ...............................................63 1.3.2.3 Thromboxanes ............................................64 1.3.2.4 Isoprostanes and Analogues .......................64 1.3.2.5 Prostanoid Derivatives ................................67 1.4 Fatty Alcohols .........................................................................70 1.4.1 Linear-Chain Fatty Alcohols ......................................70 1.4.2 Branched-Chain Fatty Alcohols .................................73 1.4.2.1 Monomethylated Alcohols ..........................73 1.4.2.2 Polymethylated Alcohols (Isoprenoid) .................................................73 1.4.2.3 β-Branched Alcohols .................................. 75 1.4.3 Phenolic Alcohols ....................................................... 75 1.5 Fatty Aldehydes .......................................................................77 1.6 Fatty Ketones ...........................................................................78 1.6.1 Simple Ketones ...........................................................79 1.6.2 Hydroxylated Ketones ................................................80 1.6.3 Cyclic Ketones ............................................................80 1.7 Long-Chain Amino Alcohols .................................................. 81 1.8 Phenolic or Quinone Lipids .....................................................84 1.8.1 Catecholic Lipids ........................................................85 1.8.2 Resorcinolic Lipids .....................................................86 1.8.3 Simple Alkylphenols ..................................................87 1.8.4 Alkylated Quinones ...................................................88 Contents vii 1.9 Prenylated Lipids .....................................................................89 1.9.1 Terpenes .....................................................................90 1.9.1.1 Monoterpenes ............................................. 91 1.9.1.2 Sesquiterpenes ............................................95 1.9.1.3 Diterpenes ................................................. 102 1.9.1.4 Triterpenes ................................................106 1.9.1.5 Carotenoids (Tetraterpenes) ...................... 107 1.9.1.6 Polyterpenes (C ≥ 45) ................................ 111 1.9.2 Terpenic Derivatives ................................................. 112 1.9.2.1 Steroids ..................................................... 112 1.9.2.2 Hopanoids ................................................. 140 1.9.2.3 Apocarotenoids ......................................... 143 1.9.2.4 Prenylated Phenols: Vitamin E ................. 149 1.9.2.5 Prenylated Quinones ................................. 154 1.9.2.6 Chlorophylls .............................................. 159 References ........................................................................................ 160 Chapter 2 Simple Lipids with Two Different Components ............................... 169 2.1 Acylglycerols ......................................................................... 169 2.1.1 Monoacylglycerols...................................................
Load more

Recommended publications
  • TC-90 High Gamma Mixed Tocopherols
    TC-90 High Gamma Mixed Tocopherols Cambridge Commodities Chemwatch Hazard Alert Code: 2 Part Number: P28128 Issue Date: 24/07/2019 Version No: 2.5.22.11 Print Date: 23/09/2021 Safety data sheet according to REACH Regulation (EC) No 1907/2006, as amended by UK REACH Regulations SI 2019/758 S.REACH.GB.EN SECTION 1 Identification of the substance / mixture and of the company / undertaking 1.1. Product Identifier Product name TC-90 High Gamma Mixed Tocopherols Chemical Name Not Applicable Synonyms Not Available ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S. (contains gamma-tocopherol, beta-tocotrienol, delta- Proper shipping name tocopherol, sunflower oil and alpha-tocopherol) Chemical formula Not Applicable Other means of P28128 identification 1.2. Relevant identified uses of the substance or mixture and uses advised against Relevant identified uses Use according to manufacturer's directions. Uses advised against Not Applicable 1.3. Details of the supplier of the safety data sheet Registered company name Cambridge Commodities Address Lancaster Way Business Park, Ely, Cambridgeshire Cambridgeshire CB6 3NX United Kingdom Telephone +44 1353 667258 Fax Not Available Website Not Available Email [email protected] 1.4. Emergency telephone number Association / Organisation Not Available Emergency telephone Not Available numbers Other emergency Not Available telephone numbers Product code: P28128 Version No: 2.5.22.2 Page 1 of 25 S.REACH.GB.EN Lancaster Way Business Park Safety Data Sheet (Conforms to Regulation (EU) No 2020/878) Ely, Cambridgeshire, CB6 3NX, UK. Chemwatch: 9-596035 +44 (0) 1353 667258 Issue Date: 24/07/2019 [email protected] Print Date: 23/09/2021 www.c-c-l.com SECTION 2 Hazards identification 2.1.
    [Show full text]
  • Epomes Act As Immune Suppressors in a Lepidopteran Insect
    www.nature.com/scientificreports OPEN EpOMEs act as immune suppressors in a lepidopteran insect, Spodoptera exigua Mohammad Vatanparast1, Shabbir Ahmed1, Dong‑Hee Lee2, Sung Hee Hwang3, Bruce Hammock3 & Yonggyun Kim1* Epoxyoctadecamonoenoic acids (EpOMEs) are epoxide derivatives of linoleic acid (9,12‑octadecadienoic acid) and include 9,10‑EpOME and 12,13‑EpOME. They are synthesized by cytochrome P450 monooxygenases (CYPs) and degraded by soluble epoxide hydrolase (sEH). Although EpOMEs are well known to play crucial roles in mediating various physiological processes in mammals, their role is not well understood in insects. This study chemically identifed their presence in insect tissues: 941.8 pg/g of 9,10‑EpOME and 2,198.3 pg/g of 12,13‑EpOME in fat body of a lepidopteran insect, Spodoptera exigua. Injection of 9,10‑EpOME or 12,13‑EpOME into larvae suppressed the cellular immune responses induced by bacterial challenge. EpOME treatment also suppressed the expression of antimicrobial peptide (AMP) genes. Among 139 S. exigua CYPs, an ortholog (SE51385) to human EpOME synthase was predicted and its expression was highly inducible upon bacterial challenge. RNA interference (RNAi) of SE51385 prevented down‑regulation of immune responses at a late stage (> 24 h) following bacterial challenge. A soluble epoxide hydrolase (Se-sEH) of S. exigua was predicted and showed specifc expression in all development stages and in diferent larval tissues. Furthermore, its expression levels were highly enhanced by bacterial challenge in diferent tissues. RNAi reduction of Se‑sEH interfered with hemocyte‑spreading behavior, nodule formation, and AMP expression. To support the immune association of EpOMEs, urea‑based sEH inhibitors were screened to assess their inhibitory activities against cellular and humoral immune responses of S.
    [Show full text]
  • Fatty Acids & Derivatives
    Conditions of Sale Validity The Conditions of Sale apply to the written text in this Catalogue superseding earlier texts related to such conditions. Intention of Use Our products are intended for research purposes only. Prices See under Order Information. All prices in this catalogue are net prices in Euro, ex works. Taxes, shipping costs or other external costs demanded by the buyer are invoiced. Delivery See under Order Information – shipping terms. Payment terms Payment terms are normally net 30 days. Deductions are not accepted unless we have issued a credit note. We accept payment by credit card (Visa/ Mastercard), bank transfer (wiring) or by cheque. If payment by cheque we will add a bank fee to our invoice. Complaints Complaints about a product or products must be made inside 30 days from the invoice date. All claims must specify batch (lot) and invoice numbers. Return of goods will not be accepted unless authorized by us. Insurance Insurance will not be made unless otherwise instructed. Delays We cannot accept compensation claims due to delays or non-deliveries. We reserve us the right to withdraw from delivery due to long term shortage of starting materials, production breakdown or other circumstances beyond our control. Warranty and All products in this catalogue are warranted to be free of defects and in Compensation Claims accordance with given specifications. If this warranty does not comply with specifications, any indemnities will be limited to not exceed the price paid for the goods. Acceptance Placing of an order implies acceptance of our conditions of sale. We accept credit cards (Visa/ Mastercard) www.larodan.se [email protected] +46 40 16 41 55 1 Ordering Information You can easily order from Larodan – please contact our local distributor or us by phone, e-mail, fax or letter.
    [Show full text]
  • Metabolism Pathways of Arachidonic Acids: Mechanisms and Potential Therapeutic Targets
    Signal Transduction and Targeted Therapy www.nature.com/sigtrans REVIEW ARTICLE OPEN Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets Bei Wang1,2,3, Lujin Wu1,2, Jing Chen1,2, Lingli Dong3, Chen Chen 1,2, Zheng Wen1,2, Jiong Hu4, Ingrid Fleming4 and Dao Wen Wang1,2 The arachidonic acid (AA) pathway plays a key role in cardiovascular biology, carcinogenesis, and many inflammatory diseases, such as asthma, arthritis, etc. Esterified AA on the inner surface of the cell membrane is hydrolyzed to its free form by phospholipase A2 (PLA2), which is in turn further metabolized by cyclooxygenases (COXs) and lipoxygenases (LOXs) and cytochrome P450 (CYP) enzymes to a spectrum of bioactive mediators that includes prostanoids, leukotrienes (LTs), epoxyeicosatrienoic acids (EETs), dihydroxyeicosatetraenoic acid (diHETEs), eicosatetraenoic acids (ETEs), and lipoxins (LXs). Many of the latter mediators are considered to be novel preventive and therapeutic targets for cardiovascular diseases (CVD), cancers, and inflammatory diseases. This review sets out to summarize the physiological and pathophysiological importance of the AA metabolizing pathways and outline the molecular mechanisms underlying the actions of AA related to its three main metabolic pathways in CVD and cancer progression will provide valuable insight for developing new therapeutic drugs for CVD and anti-cancer agents such as inhibitors of EETs or 2J2. Thus, we herein present a synopsis of AA metabolism in human health, cardiovascular and cancer biology, and the signaling pathways involved in these processes. To explore the role of the AA metabolism and potential therapies, we also introduce the current newly clinical studies targeting AA metabolisms in the different disease conditions.
    [Show full text]
  • Identification of Two Epoxide Hydrolases in Caenorhabditis
    Available online at www.sciencedirect.com ABB Archives of Biochemistry and Biophysics 472 (2008) 139–149 www.elsevier.com/locate/yabbi Identification of two epoxide hydrolases in Caenorhabditis elegans that metabolize mammalian lipid signaling molecules Todd R. Harris a, Pavel A. Aronov a, Paul D. Jones b, Hiromasa Tanaka a, Michael Arand c, Bruce D. Hammock a,* a Department of Entomology and Cancer Research Center, University of California, One Shields Avenue, Davis, CA 95616, USA b International Flavors and Fragrances, 1515 State Highway 36, Union Beach, NJ 07735, USA c Institute of Pharmacology and Toxicology, University of Zu¨rich, Winterthurerstrasse 190, CH-8057 Zu¨rich, Switzerland Received 11 September 2007, and in revised form 12 January 2008 Available online 31 January 2008 Abstract We have identified two genes in the genomic database for Caenorhabditis elegans that code for proteins with significant sequence similarity to the mammalian soluble epoxide hydrolase (sEH). The respective transcripts were cloned from a mixed stage cDNA library from C. elegans. The corresponding proteins obtained after recombinant expression in insect cells hydrolyzed standard epoxide hydrolase substrates, including epoxyeicosatrienoic acids (EETs) and leukotoxins (EpOMEs). The enzyme activity was inhibited by urea-based compounds originally designed to inhibit the mammalian sEH. In vivo inhibition of the enzymes using the most potent of these com- pounds resulted in elevated levels of the EpOMEs in the nematode. These results suggest that the hydrolases are involved in the metab- olism of possible lipid signaling molecules in C. elegans. Ó 2008 Elsevier Inc. All rights reserved. Keywords: Soluble epoxide hydrolase; Lipid signaling; Epoxyeicosatrienoic acid; Leukotoxin; 9,10-Epoxy-12-octadecenoate; 12,13-Epoxy-9-octadecenoate Soluble epoxide hydrolase (sEH)1, an enzyme first char- In mammals, the epoxide hydrolase activity of sEH has acterized in mammals, hydrolyzes an epoxide moiety been implicated in the metabolism of several epoxide-con- through the addition of water [1,2].
    [Show full text]
  • Cytochrome P4502S1: a Novel Monocyte/Macrophage Fatty Acid Epoxygenase in Human Atherosclerotic Plaques
    Basic Res Cardiol (2013) 108:319 DOI 10.1007/s00395-012-0319-8 ORIGINAL CONTRIBUTION Cytochrome P4502S1: a novel monocyte/macrophage fatty acid epoxygenase in human atherosclerotic plaques Timo Fro¨mel • Karin Kohlstedt • Ru¨diger Popp • Xiaoke Yin • Khader Awwad • Eduardo Barbosa-Sicard • Anita C. Thomas • Ralf Lieberz • Manuel Mayr • Ingrid Fleming Received: 30 April 2012 / Revised: 2 November 2012 / Accepted: 26 November 2012 Ó Springer-Verlag Berlin Heidelberg 2012 Abstract Cytochrome P450 (CYP) epoxygenases LPS and IFN-c (classically activated), and oxidized LDL metabolize endogenous polyunsaturated fatty acids to their but not IL-4 and IL-13 (alternatively activated), and was corresponding epoxides, generating bioactive lipid media- colocalised with CD68 in inflamed human tonsils but not in tors. The latter play an important role in vascular homeo- breast cancer metastases. Prostaglandin (PG) E2 is an stasis, angiogenesis, and inflammation. As little is known immune modulator factor that promotes phagocytosis and about the functional importance of extra-vascular sources of CYP2S1 can metabolize its immediate precursors PGG2 lipid epoxides, we focused on determining whether lipid and PGH2 to 12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic epoxide-generating CYP isoforms are expressed in human acid (12-HHT). We found that CYP inhibition and siRNA- monocytes/macrophages. Epoxides were generated by mediated downregulation of CYP2S1 increased macro- freshly isolated human monocytes and production increased phage phagocytosis and that the latter effect correlated with markedly during differentiation to macrophages. Mass decreased 12-HHT formation. Although no Cyp2s1 protein spectrometric analysis identified CYP2S1 as a novel mac- was detected in aortae from wild-type mice it was expressed rophage CYP and CYP2S1-containing microsomes gener- in aortae and macrophage foam cells from ApoE-/- mice.
    [Show full text]
  • FULLTEXT01.Pdf
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ill Mamma och Pappa Supervisor Professor Ernst H. Oliw Faculty opponent Professor Leif Bertilsson Members of the examining board Dr. Maria Norlin Docent Inger Johansson Professor Leif Jansson List of Original Papers Th is thesis is based on the following original papers,
    [Show full text]
  • ABB Archives of Biochemistry and Biophysics 472 (2008) 139–149
    Available online at www.sciencedirect.com ABB Archives of Biochemistry and Biophysics 472 (2008) 139–149 www.elsevier.com/locate/yabbi Identification of two epoxide hydrolases in Caenorhabditis elegans that metabolize mammalian lipid signaling molecules Todd R. Harris a, Pavel A. Aronov a, Paul D. Jones b, Hiromasa Tanaka a, Michael Arand c, Bruce D. Hammock a,* a Department of Entomology and Cancer Research Center, University of California, One Shields Avenue, Davis, CA 95616, USA b International Flavors and Fragrances, 1515 State Highway 36, Union Beach, NJ 07735, USA c Institute of Pharmacology and Toxicology, University of Zu¨rich, Winterthurerstrasse 190, CH-8057 Zu¨rich, Switzerland Received 11 September 2007, and in revised form 12 January 2008 Available online 31 January 2008 Abstract We have identified two genes in the genomic database for Caenorhabditis elegans that code for proteins with significant sequence similarity to the mammalian soluble epoxide hydrolase (sEH). The respective transcripts were cloned from a mixed stage cDNA library from C. elegans. The corresponding proteins obtained after recombinant expression in insect cells hydrolyzed standard epoxide hydrolase substrates, including epoxyeicosatrienoic acids (EETs) and leukotoxins (EpOMEs). The enzyme activity was inhibited by urea-based compounds originally designed to inhibit the mammalian sEH. In vivo inhibition of the enzymes using the most potent of these com- pounds resulted in elevated levels of the EpOMEs in the nematode. These results suggest that the hydrolases are involved in the metab- olism of possible lipid signaling molecules in C. elegans. Ó 2008 Elsevier Inc. All rights reserved. Keywords: Soluble epoxide hydrolase; Lipid signaling; Epoxyeicosatrienoic acid; Leukotoxin; 9,10-Epoxy-12-octadecenoate; 12,13-Epoxy-9-octadecenoate Soluble epoxide hydrolase (sEH)1, an enzyme first char- In mammals, the epoxide hydrolase activity of sEH has acterized in mammals, hydrolyzes an epoxide moiety been implicated in the metabolism of several epoxide-con- through the addition of water [1,2].
    [Show full text]
  • Cytochrome P450 Monooxygenase-Mediated Lipid Metabolism in Obesity and Colon Tumorigenesis
    University of Massachusetts Amherst ScholarWorks@UMass Amherst Doctoral Dissertations Dissertations and Theses October 2019 CYTOCHROME P450 MONOOXYGENASE-MEDIATED LIPID METABOLISM IN OBESITY AND COLON TUMORIGENESIS Weicang Wang University of Massachusetts Amherst Follow this and additional works at: https://scholarworks.umass.edu/dissertations_2 Part of the Digestive System Diseases Commons, Food Chemistry Commons, and the Lipids Commons Recommended Citation Wang, Weicang, "CYTOCHROME P450 MONOOXYGENASE-MEDIATED LIPID METABOLISM IN OBESITY AND COLON TUMORIGENESIS" (2019). Doctoral Dissertations. 1778. https://doi.org/10.7275/14655356 https://scholarworks.umass.edu/dissertations_2/1778 This Open Access Dissertation is brought to you for free and open access by the Dissertations and Theses at ScholarWorks@UMass Amherst. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of ScholarWorks@UMass Amherst. For more information, please contact [email protected]. CYTOCHROME P450 MONOOXYGENASE-MEDIATED LIPID METABOLISM IN OBESITY AND COLON TUMORIGENESIS A Dissertation Presented by WEICANG WANG Submitted to the Graduate School of the University of Massachusetts Amherst in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY September 2019 The Department of Food Science © Copyright by Weicang Wang 2019 All Rights Reserved CYTOCHROME P450 MONOOXYGENASE-MEDIATED LIPID METABOLISM IN OBESITY AND COLON TUMORIGENESIS A Dissertation Presented by WEICANG WANG Approved as to style and content by: ___________________________________ Guodong Zhang, Chair ___________________________________ Hang Xiao, Member ___________________________________ Zhenhua Liu, Member ___________________________________ Eric A. Decker, Department Head Department of Food Science DEDICATION To my great parents, wonderful wife, All of my families and friends ACKNOWLEDGMENTS I would like to express my heartfelt appreciation to my advisor, Prof.
    [Show full text]
  • Epoxygenase Expression in Soybean and Biological Effects of Epoxy Fatty Acids
    University of Kentucky UKnowledge University of Kentucky Master's Theses Graduate School 2006 EPOXYGENASE EXPRESSION IN SOYBEAN AND BIOLOGICAL EFFECTS OF EPOXY FATTY ACIDS Purnima Kamlakar Wagh University of Kentucky, [email protected] Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Wagh, Purnima Kamlakar, "EPOXYGENASE EXPRESSION IN SOYBEAN AND BIOLOGICAL EFFECTS OF EPOXY FATTY ACIDS" (2006). University of Kentucky Master's Theses. 384. https://uknowledge.uky.edu/gradschool_theses/384 This Thesis is brought to you for free and open access by the Graduate School at UKnowledge. It has been accepted for inclusion in University of Kentucky Master's Theses by an authorized administrator of UKnowledge. For more information, please contact [email protected]. ABSTRACT OF THESIS EPOXYGENASE EXPRESSION IN SOYBEAN AND BIOLOGICAL EFFECTS OF EPOXY FATTY ACIDS Epoxy fatty acids (EXA) are valuable to industry as they are used in synthesizing plasticizers such as of poly vinyl chloride, resins, adhesives, coating materials such as paint, lubricant, lubricant additives, insecticides, insect repellants, crop oil concentrates and formulations of carriers for slow release pesticides and herbicides. There is interest in developing commercial oilseeds accumulating epoxy fatty acids to at least 50% of the seed oil. Soybeans are the most widely cultivated oilseed and its oil has high levels of linoleic acid which can be a substrate for epoxygenase enzymes. Cahoon et al., expressed a cytochrome P450 enzyme (CYP726A1) from Euphorbia lagascae in soybean somatic embryos and found that the epoxy fatty acid, vernolic acid, reached ~8% of the total fatty acids in transgenic somatic embryos.
    [Show full text]
  • Skin Again Ointment AU SDS
    Skin Again Ointment SEN Skin Chemwatch Hazard Alert Code: 2 Chemwatch: 5423-52 Issue Date: 07/09/2020 Version No: 2.1.1.1 Print Date: 09/09/2020 Safety Data Sheet according to WHS and ADG requirements S.GHS.AUS.EN SECTION 1 Identification of the substance / mixture and of the company / undertaking Product Identifier Product name Skin Again Ointment Synonyms Not Available Other means of Not Available identification Relevant identified uses of the substance or mixture and uses advised against Hand Sanitiser. For external use only, apply a few pumps of hand sanitiser on palm of hands and rub gently on both hands until Relevant identified uses completely dry for around 20 seconds. Use according to manufacturer's directions. Details of the supplier of the safety data sheet Registered company name SEN Skin Address Level 1/1966 Beach Road Malaga WA 6090 Australia Telephone 9200 5872 Fax Not Available Website www.senskin.com.au Email [email protected] Emergency telephone number Association / Organisation SEN Skin Emergency telephone 1800 838 064 numbers Other emergency Not Available telephone numbers SECTION 2 Hazards identification Classification of the substance or mixture HAZARDOUS CHEMICAL. NON-DANGEROUS GOODS. According to the WHS Regulations and the ADG Code. Poisons Schedule Not Applicable Classification [1] Eye Irritation Category 2A 1. Classified by Chemwatch; 2. Classification drawn from HCIS; 3. Classification drawn from Regulation (EU) No 1272/2008 - Legend: Annex VI Label elements Hazard pictogram(s) Signal word Warning Page 1 continued... Chemwatch: 5423-52 Page 2 of 14 Issue Date: 07/09/2020 Version No: 2.1.1.1 Skin Again Ointment Print Date: 09/09/2020 Hazard statement(s) H319 Causes serious eye irritation.
    [Show full text]
  • Mixed Tocopherol 50%
    Mixed tocopherol 50% Oil Cambridge Commodities Chemwatch Hazard Alert Code: 2 Part Number: P20028 Issue Date: 02/04/2019 Version No: 1.1 Print Date: 05/10/2021 Safety data sheet according to REACH Regulation (EC) No 1907/2006, as amended by UK REACH Regulations SI 2019/758 S.REACH.GB.EN SECTION 1 Identification of the substance / mixture and of the company / undertaking 1.1. Product Identifier Product name Mixed tocopherol 50% Oil Chemical Name Not Available Synonyms Not Available ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S. (contains beta-tocopherol, gamma-tocopherol, delta- Proper shipping name tocopherol, sunflower oil and alpha-tocopherol) Chemical formula Not Available Other means of P20028 identification CAS number Not Available REACH registration Not Available number 1.2. Relevant identified uses of the substance or mixture and uses advised against Relevant identified uses Use according to manufacturer's directions. Uses advised against Not Applicable 1.3. Details of the supplier of the safety data sheet Registered company name Cambridge Commodities Address Lancaster Way Business Park, Ely, Cambridgeshire Cambridgeshire CB6 3NX United Kingdom Telephone +44 1353 667258 Fax Not Available Website Not Available Email [email protected] 1.4. Emergency telephone number Association / Organisation Not Available Product code: P20028 Version No: 1.1 Page 1 of 30 S.REACH.GB.EN Lancaster Way Business Park Safety Data Sheet (Conforms to Regulation (EU) No 2020/878) Ely, Cambridgeshire, CB6 3NX, UK. Chemwatch: 9-644833 +44 (0) 1353 667258 Issue Date: 02/04/2019 [email protected] Print Date: 05/10/2021 www.c-c-l.com Emergency telephone Not Available numbers Other emergency Not Available telephone numbers SECTION 2 Hazards identification 2.1.
    [Show full text]